Wednesday, June 10, 2026

Intelligence Β· INN directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed 4,797
Companies 1,769
Pipeline programs 20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 122 of 200 Β· By data quality, then INN

  1. diphtheria, tetanus and pertussis (acellular, component) vaccine (adsorbed)

    TRIACELLUVAX

    EMA: withdrawn

    J07AJ
  2. diphtheria, tetanus, acellular pertussis and hepatitis b recombinant, adsorbed vaccine

    INFANRIX HEPB

    EMA: withdrawn

    J07CA
  3. diphtheria, tetanus, acellular pertussis, inactivated poliomyelitis, hepatitis b (recombinant) and haemophilus influenzae type b conjugate vaccine, adjuvanted

    HEXAVAC

    EMA: withdrawn

    J07CA
  4. diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed)

    HEXYON

    EMA: approved

    J07CA09
  5. diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inactivated) and haemophilus type b conjugate vaccine (adsorbed)

    VAXELIS

    EMA: approved

    J07CA09
  6. diphtheria, tetanus, pertussis (whole cell), hepatitis b (rdna) and haemophilus influenzae type b conjugate vaccine (absorbed)

    QUINTANRIX

    EMA: withdrawn

    J07CA10
  7. dodecafluoropentane

    ECHOGEN

    EMA: withdrawn

    V08DA
  8. donanemab

    KISUNLA

    EMA: approved Β· PMDA: approved

    N06DX05
  9. donidalorsen

    DAWNZERA

    EMA: approved

    B06AC
  10. dostarlimab

    JEMPERLI GlaxoSmithKline

    EMA: approved Β· TGA: approved

    L01FF07
  11. doxorubicin

    ADRIAMYCIN Pfizer Australia Pty Ltd

    EMA: approved Β· TGA: approved Β· NMPA: clinical trials

    L01DB
  12. drotrecogin alfa (activated)

    XIGRIS

    EMA: withdrawn

    B01AD10
  13. dry aqueous extract of paullinia cupana seed

    CINAINU

    EMA: application withdrawn

  14. ebola vaccine (ad26.zebov-gp [recombinant])

    ZABDENO

    EMA: withdrawn

    J07
  15. ebola vaccine (mva-bn-filo [recombinant])

    MVABEA

    EMA: withdrawn

    J07BX
  16. ebola zaire vaccine (rvsvβˆ†g-zebov-gp, live)

    ERVEBO

    EMA: approved

  17. edotreotide

    SOMAKIT TOC

    EMA: approved

    V09IX
  18. efalizumab

    RAPTIVA

    EMA: withdrawn

    L04AA21
  19. efanesoctocog alfa

    ALTUVOCT

    EMA: approved

    B02BD02
  20. efbemalenograstim alfa

    RYZNEUTA

    EMA: approved

    L03AA18
  21. efmoroctocog alfa

    ELOCTA

    EMA: approved

    B02BD02
  22. eftrenonacog alfa

    ALPROLIX

    EMA: approved

    B02BD04
  23. efungumab

    MYCOGRAB

    EMA: refused

    J02
  24. elacestrant

    ORSERDU

    EMA: approved

    L02BA

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles β€” INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page β€” it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.